Corneal perforation associated with topically applied gatifloxacin

Abdulrahman Mohammed Al-Amri1

  • 1Department of Ophthalmology, College of Medicine, King Khalid University, Abha, Saudi Arabia. amaamri@hotmail.com

Cornea
|March 26, 2008
PubMed
Abstract

Insights

Gatifloxacin use for inflamed pterygium may lead to corneal perforation. Prompt management with cyanoacrylate glue and surgery is crucial for this sight-threatening complication.

Area of Science:

  • Ophthalmology
  • Corneal Surgery
  • Pharmacovigilance

Background:

  • Pterygium is a common ocular condition.
  • Inflamed pterygium requires treatment.
  • Gatifloxacin is an antibiotic used in ophthalmic preparations.

Observation:

  • A 30-year-old male patient developed corneal perforation.
  • The perforation occurred after treatment with gatifloxacin for inflamed pterygium.

Findings:

  • Discontinuation of gatifloxacin was the first step in management.
  • Corneal perforation was successfully treated with cyanoacrylate glue.
  • Subsequent pterygium excision was performed.

Implications:

  • Gatifloxacin may be associated with an increased risk of corneal perforation in patients with inflamed pterygium.
  • Ophthalmologists should exercise caution when prescribing gatifloxacin for pterygium.
  • Further research is warranted to confirm this association and elucidate the mechanism.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.